Mar. 5 at 2:56 AM
$BCTX Started a position here at
$3.98. Binary event catalyst in H1 2026.
$30M cash in bank after recent offering.
The interim analysis is the most critical near-term event. Given they had 160+ patients enrolled as of December 2025 and need 144 death events, and this is a late-stage metastatic patient population, the interim readout is likely weeks to 2-3 months away, not quarters.
